Dr. Daniela Gornyk
Dr. Daniela Gornyk
Research focus
- Epidemiology
- Cross-border health research
- Scientific coordination
Academic training
| 2017 - 2022 | PhD in Epidemiology, Hannover Medical School |
| 2008 - 2011 | Master's degree in Public Health (MPH), Hannover Medical School |
| 2002 - 2007 | Diplom in Business Administration, University of Applied Sciences Hildesheim |
Scientific career
| Since 2025 | Research Associate, Department of Health Economics, University of Oldenburg |
| 2024 | External Internship Supervisor, Vrije Universiteit Amsterdam (NL) |
| 2022 - 2023 | Assistant Director at Xcenda GmbH Hanover (Part of Cencora), Real World Evidence Department, Hanover |
| 2022 | PostDoc position, TransCareTech project, FH Bielefeld - University of Applied Sciences |
| 2022 | Deputy Head of the NAKO Study Centre in Hanover, Helmholtz Centre for Infection Research GmbH, Braunschweig |
| 2017 - 2021 | PhD position, Helmholtz Centre for Infection Research GmbH, Braunschweig |
| 2020 | Research Associate, Team Lead Seroprevalence Study, Helmholtz Centre for Infection Research GmbH, Braunschweig |
| 2015 - 2017 | Research Associate, Department of Pharmacoepidemiology, German Centre for Neurodegenerative Diseases Bonn |
| 2012 - 2015 | Data Analyser, Department of Contract Management, Association of Statutory Health Insurance Physicians Bremen |
| 2012 | Research assistant, University Cancer Centre Hamburg, University Medical Center Hamburg-Eppendorf |
| 2007 - 2008 | Key Account Manager, Lurch AG, Hildesheim |
Publications in first authorship
| Gornyk D, Harries M, Glöckner S, Strengert M, Kerrinnes T, Heise JK, Maaß H, Ortmann J, Kessel B, Kemmling Y, Lange B, Krause G and the MuSPAD team: SARS-CoV-2 seroprevalence in Germany-a population-based sequential study in seven regions. Dtsch Arztebl Int 2021; 118. DOI: 10.3238/arztebl.m2021.0364 |
| Gornyk D, Scharlach M, Buhr-Riehm B, Klett-Tammen CJ, Eberhard S, Stahmeyer JT, Großhennig A, Smith A, Meinicke S, Bautsch W: Effectiveness of trainings of General Practitioners on antibiotic stewardship: A pragmatic quasi-experimental study in a controlled before-after design in South-East- Lower Saxony, Germany (WASA). Front. Pharmacol; 2021, 12:614 |
| Obi N, Gornyk D, Heinz J, Vrieling A, Seibold P, Chang-Claude J, Flesch-Janys D. Determinants of newly diagnosed comorbidities among breast cancer survivors. J Cancer Surviv. 2014 Sep;8(3):384- 93. doi: 10.1007/s11764-013-0338-y. Epub 2014 Feb 26. PMID: 24570215. |
Further publications
| Dulovic A, Kessel B, Harries M, Becker M, Ortmann J, Griesbaum J, Jüngling J, Junker D, Hernandez P, Gornyk D, Glöckner S, Melhorn V, Castell S, Heise JK, Kemmling Y, Tonn T, Frank K, Illig T, Klopp N, Warikoo N, Rath A, Suckel C, Marzian AU, Grupe N, Kaiser PD, Traenkle B, Rothbauer U, Kerrinnes T, Krause G, Lange B, Schneiderhan-Marra N, Strengert M. Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany. Front Immunol. 2022 Feb 16;13:828053. doi: 10.3389/fimmu.2022.828053. PMID: 35251012; PMCID: PMC8888837. |
| Häring J, Hassenstein MJ, Becker M, Ortmann J, Junker D, Karch A, Berger K, Tchitchagua T, Leschnik O, Harries M, Gornyk D, Hernández P, Lange B, Castell S, Krause G, Dulovic A, Strengert, M, Schneiderhan-Marra N. Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies. BMC Infect Dis. 2022 Nov 17;22(1):859. doi: 10.1186/s12879-022-07863-9. PMID: 36396985; PMCID: PMC9670078. |
| acobsen H, Strengert M, Maaß H, Ynga Durand MA, Katzmarzyk M, Kessel B, Harries M, Rand U, Abassi L, Kim Y, Lüddecke T, Metzdorf K, Hernandez P, Ortmann J, Heise JK, Castell S, Gornyk D, Glöckner S, Melhorn V, Kemmling Y, Lange B, Dulovic A, Marsall P, Häring J, Junker D, Schneiderhan- Marra N, Hoffmann M, Pöhlmann S, Krause G, Cicin-Sain L. Diminished neutralisation responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations. Sci Rep. 2022 Nov 18;12(1):19858. doi: 10.1038/s41598-022-22552-y. PMID: 36400804; PMCID: PMC9673895. |
| Kettlitz R, Harries M, Ortmann J, Krause G; MuSPAD Team; Aigner A, Lange B. Association of known SARS-CoV-2 serostatus and adherence to personal protection measures and the impact of personal protective measures on seropositivity in a population-based cross-sectional study (MuSPAD) in Germany. BMC Public Health. 2023 Nov 17;23(1):2281. doi: 10.1186/s12889-023-17121-5. PMID: 37978484; PMCID: PMC10657116. |